Free Trial

HEALTHCARE: Roche (ROSW: Aa2/AA): Investor Day

HEALTHCARE

Roche is having an Investor Day today. See link below for the presentation

  • Equity market is unchanged.
  • Steamlining company into Diagnostics and Pharma
  • Aiming for 20 transformative medicines over the decade
  • +40% growth in average peak sales
  • Vabysmo (wet age related macular degeneration) is the main blockbuster
  • Have identified two new classes of antibiotics (Zosurabalpin & LepBi) which we can all be grateful for.

Link to IR

60 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Roche is having an Investor Day today. See link below for the presentation

  • Equity market is unchanged.
  • Steamlining company into Diagnostics and Pharma
  • Aiming for 20 transformative medicines over the decade
  • +40% growth in average peak sales
  • Vabysmo (wet age related macular degeneration) is the main blockbuster
  • Have identified two new classes of antibiotics (Zosurabalpin & LepBi) which we can all be grateful for.

Link to IR